SCHEMBL6336154

SCHEMBL6336154

CCSCCC(C)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21573189 1.00
SCHEMBL20959627 0.84
SCHEMBL27253724 0.81
SCHEMBL21934762 0.78 GABRP (0.39)
SCHEMBL19817584 0.78 BHMT (0.38)
SCHEMBL22509361 0.77 OPRM1 (0.54)
SCHEMBL1704558 0.77
SCHEMBL20661539 0.76
SCHEMBL8991438 0.74
SCHEMBL22140645 0.74 METAP2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3079015-B1 PHOTOMASK BLANK, RESIST PATTERN FORMING PROCESS, AND METHOD FOR MAKING PHOTOMASK SHINETSU CHEMICAL CO (JP) 2020-04-29 EP disclosed
US-6861423-B2 Methods of treating p38 kinase-mediated disorders with pyrido[2,3-d]pyrimidin-7-one compounds SYNTEX (U.S.A.) LLC (US) 2005-03-01 US disclosed
US-20040192709-A1 7-oxo-pyridopyrimidines (II) SYNTEX (U.S.A.) LLC 2004-09-30 US disclosed
US-6753427-B2 2,6-DISUBSTITUTED 7-OXOPYRIDO(2,3-D)PYRIMIDINES; INHIBITORS OF PROTEIN KINASES; TREATING DISEASES MEDIATED BY THE PRO-INFLAMMATORY CYTOKINES, E.G., TUMOR NECROSIS FACTOR, INTER-LEUKINS, CYCLOXYGENASE; CHRONIC OBSTRUCTIVE PULMONARY DISEASE SYNTEX (U.S.A.) LLC 2004-06-22 US disclosed
US-20030153586-A1 7-oxo-pyridopyrimidines (I) SYNTEX (U.S.A) LLC 2003-08-14 US disclosed
US-20030144307-A1 7-oxo-pyridopyrimidines (II) ARZENO HUMBERTO BARTOLOME (US) 2003-07-31 US disclosed
EP-1315726-A1 7- OXO PYRIDOPYRIMIDINES AS INHIBITORS OF CELLULAR PROLIFERATION F. HOFFMANN-LA ROCHE AG (CH) 2003-06-04 EP disclosed
US-6518276-B2 Treating a p38 mediated disorders SYNTEX (U.S.A.) LLC 2003-02-11 US disclosed
US-6506749-B2 Mitogen-activated protein kinases inhibitors SYNTEX (U.S.A.) LLC 2003-01-14 US disclosed
US-20020137756-A1 Mitogen-activated protein kinases inhibitors SYNTEX (U.S.A.) LLC 2002-09-26 US disclosed
US-20020055513-A1 7-oxo-pyridopyrimidines (II) SYNTEX (U.S.A.) LLC 2002-05-09 US disclosed
WO-2002018380-A1 7-OXO PYRIDOPYRIMIDINES AS INHIBITORS OF A CELLULAR PROLIFERATION F. HOFFMANN-LA ROCHE AG (CH) 2002-03-07 WO disclosed